Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3420
Source ID: NCT01293396
Associated Drug: Insulin Aspart
Title: Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids
Acronym: HUCKEPACK2
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT01293396/results
Conditions: Type 2 Diabetes
Interventions: DRUG: Insulin Aspart|DRUG: Insulin Aspart 30|DRUG: Insulin Aspart 70
Outcome Measures: Primary: Area Over Basal for Postprandial Glucose From 0 to 600min, Area over basal for postprandial glucose from 0 (Fasting glucose, measured at daily study start) to 600 min (after breakfast) Area over basal is calculated according to the trapezoidal rule., 0,30,60,90,120,180,240,270,300,330,360,420,480,540,600 minutes post-dose (daily study start)|Area Over Basal for Postprandial Triglycerides, Area over basal for postprandial triglycerides from 0 (Fasting triglycerides, measured at daily study start) to 600 min (after breakfast) Area over basal is calculated according to the trapezoidal rule., 0,30,60,90,120,180,240,270,300,330,360,420,480,540,600 minutes post-dose (daily study start) | Secondary: Maximum Glucose Increase, Maximum glucose increase from baseline to 600min after baseline, 0,30,60,90,120,180,240,270,300,330,360,420,480,540,600 minutes post-dose (daily study start)|Maximum Triglyceride Increase, Maximum trigylceride increase from Baseline to 600min after Baseline, 0,30,60,90,120,180,240,270,300,330,360,420,480,540,600 minutes post-dose (daily study start)|Area Over Basal for Postprandial Insulin, Area over basal for postprandial insulin from 0 (Fasting insulin, measured at daily study start) to 600 min (after breakfast) Area over basal is calculated according to the trapezoidal rule., 0,30,60,90,120,180,240,270,300,330,360,420,480,540,600 minutes post-dose (daily study start)|Area Over Basal for Postprandial C-peptide, Area over basal for postprandial c-peptide from 0 (Fasting c-peptide, measured at daily study start) to 600 min (after breakfast) Area over basal is calculated according to the trapezoidal rule., 0,30,60,90,120,180,240,270,300,330,360,420,480,540,600 minutes post-dose (daily study start)
Sponsor/Collaborators: Sponsor: Medical University of Graz
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 20
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2010-06
Completion Date: 2011-03
Results First Posted: 2021-06-30
Last Update Posted: 2021-06-30
Locations: Medical University of Graz, Department for Internal Medicine, Graz, 8036, Austria
URL: https://clinicaltrials.gov/show/NCT01293396